BUTALBITAL, ACETAMIN

The contract, awarded on July 14, 2026, is a delivery order under the indefinite-delivery, indefinite-quantity basic contract SPE2DX-25-D-9900 issued by the Defense Logistics Agency to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0. The order, numbered SPE2DP26F7560, is for a single line item: BUTALBITAL, ACETAMIN, with a National Stock Number of 6505012191084, at a fixed unit price of $58.59, resulting in a total contract value of $58.59. The contract specifies strict quantity controls with zero variance allowed and requires delivery by July 29, 2026, to Fort Bragg, North Carolina, under FOB Destination terms, meaning the contractor is responsible for all freight charges and risk until delivery. Packaging must utilize traceable shipping methods, prohibit parcel post, and include the Transport Control Number W91KBP60890048 along with the contract and order numbers on all documentation. Inspection and acceptance are conducted by the government at the destination point, and compliance is tied to conformity with the underlying basic contract. The awardee is certified as a Small Business and a Women-Owned Small Business, which imposes ongoing eligibility and reporting obligations. Payment will be processed through the Defense Finance and Accounting Service in Columbus, Ohio, using the payment code SL4701 and accounting line BX: 97X4930 5CBX 001 2620 S33189. No specific quality standards, preservation methods, or military packaging directives such as MIL-STDs are referenced, and no formal evaluation factors, contract clauses, or attachments are detailed in the documentation. The contracting officer is Lisa Quinn, reachable via email at [email hidden], and there is no identified contracting officer technical representative. The transaction reflects a simplified acquisition procedure, likely awarded on a Lowest Price Technically Acceptable basis due to its minimal scope, fixed pricing, and lack of complex requirements.